Molecular Biology Program

The Prasad Jallepalli Lab

Research

Pictured: Dr. Prasad Jallepalli
Prasad Jallepalli, MD, PhD
Member

Our laboratory is interested in how human cells accurately duplicate and transmit their chromosomes during each round of division.

View Lab Overview

Prasad Jallepalli Lab Group

Publications Highlights

J. Maciejowski, H. Dreschler, K. Grundner-Culemann, E.R. Ballister, J.-A. Rodriguez-Rodriguez, V. Rodriguez-Bravo, M.J.K. Jones, E. Foley, M.A. Lampson, H. Daub, A.D. McAinsh, and P.V. Jallepalli. Mps1 regulates kinetochore-microtubule attachment stability via the Ska complex to ensure error-free chromosome segregation. Dev. Cell 41, 153-156 (2017).

V. Rodriguez-Bravo, J. Maciejowski, J. Corona, H.K. Buch, M.T. Kanemaki, J.V. Shah, and P.V. Jallepalli. Nuclear pores protect genome integrity by assembling a premitotic and Mad1-dependent anaphase inhibitor. Cell 156, 1017-1031 (2014).

View All Publications

People

Pictured: Dr. Prasad Jallepalli

Prasad Jallepalli, MD, PhD

Member

  • Molecular biologist Prasad Jallepalli studies the mechanisms that ensure accurate chromosome transmission in human cells.
  • MD, PhD, Johns Hopkins University School of Medicine
[email protected]
Email Address
212-639-3252
Office Phone

Members

Prasad Jallepalli, MD, PhD
Prasad Jallepalli

Member & Professor

Jose  A. Rodriguez, PhD
Jose A. Rodriguez

Senior Research Scientist

Jayant Asthana

Senior Research Scientist

Gina Tomarchio
Gina Tomarchio

Graduate Student

Rosemary Arrieta

Research Technician

Lab Alumni
Clare Lewis, PhD
Clare Lewis
Johannes Buheitel, PhD
Johannes Buheitel

Research Scholar

John Maciejowski

Graduate Student

Jennifer Corona
Jennifer Corona

Research Assistant

Mathew Jones, PhD
Mathew Jones

Research Associate

Kelly Yule George

Graduate Student

Wei Zhang

Graduate Student

Rohit Prakash

Research Fellow

Eli Berdougo

Graduate Student

Mark Burkard

Research Fellow

Camille Gelot

Research Fellow

Maura Papi

Research Fellow

Cate Randall Paschal

Graduate Student

Sadia Rahman, PhD
Sadia Rahman

Healthcare Investment Banking, Cowen Inc., New York, NY

Veronica Rodriguez-Bravo

Research Associate

Rebecca Sherwood

Graduate Student

Marie-Emilie Terret

Research Fellow

Lab Affiliations

Achievements

  • Phi Beta Kappa, Harvard University (1992)
  • M.D./Ph.D. Fellow, Medical Scientist Training Program, Johns Hopkins University (1992-1999)
  • Postdoctoral Fellow, Damon Runyon Cancer Foundation (1999-2002)
  • Scholar, V Foundation for Cancer Research (2003)
  • Frederick R. Adler Chair for Junior Faculty (2003-2007)
Read more
  • Pew Scholar in the Biomedical Sciences (2003-2007)
  • Louise & Allston Boyer Young Investigator Award (2008)
  • Research Scholar, American Cancer Society (2008-2011)

Open Positions

To learn more about available postdoctoral opportunities, please visit our Career Center

To learn more about compensation and benefits for postdoctoral researchers at MSK, please visit Resources for Postdocs

Career Opportunity

Apply now

Get in Touch

Disclosures

Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

Prasad Jallepalli discloses the following relationships and financial interests:

No disclosures meeting criteria for time period


The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.


This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].


View all disclosures